Journal profile · Obstetrics & Gynecology
European Journal of Gynaecological Oncology
ISSN 0392-2936 · eISSN 2709-0086 · MRE PRESS · Singapore · Bimonthly · Founded 1980
European Journal of Gynaecological Oncology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.26; fully open access; APC charged, amount not published; review about 2 months (community reports); community-reported acceptance: about 75%; 124 articles in 2025; indexed in Scopus; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
European Journal of Gynaecological Oncology is published by MRE PRESS and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments and Cervical Cancer and HPV Research, together about 53.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
EJGO is dedicated to publishing editorial articles in the Distinguished Expert Series and original research papers, case reports, letters to the Editor, book reviews, and newsletters. The Journal was founded in 1980 the second gynaecologic oncology hyperspecialization Journal in the world. Its aim is the diffusion of scientific, clinical and practical progress, and knowledge in female neoplastic diseases in an interdisciplinary approach among gynaecologists, oncologists, radiotherapists, surgeons, chemotherapists, pathologists, epidemiologists, and so on.
Source: LetPub
Research area (LetPub): Obstetrics & Gynecology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Ovarian cancer diagnosis and treatmentMedicine21.5%
- Endometrial and Cervical Cancer TreatmentsMedicine19.9%
- Cervical Cancer and HPV ResearchMedicine11.7%
- Uterine Myomas and TreatmentsMedicine7.3%
- Endometriosis Research and TreatmentMedicine3.7%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology2.7%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology2.5%
- Cancer Risks and FactorsMedicine2.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Obstetrics & Gynecology | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Obstetrics & Gynecology | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
ScopusLetPub
Early warning / risk: Removed from SCIE for editorial reasons on 16 February 2026. CAS Early Warning Journal List: not listed in any of 6 editions.LetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.26LetPub ·
- CiteScore 2026-06
- 0.3LetPub ·
- SJR 2026-06
- 0.15LetPub ·
- SNIP 2026-06
- 0.11LetPub ·
- h-index
- 42LetPub ·
- h-index
- 10OpenAlex ·
- i10-index
- 12OpenAlex ·
- 2-year mean citedness
- 0.43OpenAlex ·
- Share of gold OA articles
- 97.21%LetPub ·
Volume
- Articles per year
- 151LetPub ·
Articles by year OpenAlex count · 1,401 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 19 | 19 | 4 |
| 2025 | 124 | 124 | 43 |
| 2024 | 131 | 131 | 70 |
| 2023 | 112 | 112 | 83 |
| 2022 | 110 | 110 | 787 |
| 2021 | 192 | 192 | 373 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers3, by deadline
Publisher websitePolicy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, Peer review, Plagiarism, Trial registration / reporting guidelines
- Authorship 8. Authorship
Authors’ contributions An 'author' is generally considered to be someone who has made substantive intellectual contributions to a published study. According to the ICMJE guidelines, to qualify as an author one should have 1) made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) been involved in drafting the manuscript or revisin…
Source ↗Publisher website ·- Conflicts of interest 7. Competing interests
Authors, reviewers and editors must declare whether there are any competing interests with regard to the publication of a study. A competing interests exists when the authors’ interpretation of data or presentation of information may be influenced by, or may be perceived to be influenced by, their personal or financial relationship with other people or organizations, such as reimbursement for sala…
Source ↗Publisher website ·- Data availability 6. Availability of data and materials
Data sharing strongly encouraged; availability statement required. Model summary
Submission of a manuscript to MRE Press implies that the materials included in the manuscript, including all relevant raw data, will be made freely available to any researchers who wish to use them for non-commercial purposes, while preserving any necessary confidentiality and anonymity. For MRE Press journals, it is strongly encouraged that all datasets on which the conclusions of a manuscript de…
Source ↗Publisher website ·- Publication ethics 12. Misconduct
Follows COPE guidelines and ICMJE Recommendations. Model summary
If misconduct by authors or reviewers is suspected, either pre- or post-publication action will be taken. In cases where misconduct, or otherwise unethical behaviour, on the part of the authors is suspected after a paper is published (even several years after the paper has been published), a preliminary investigation will be conducted following the guidance offered in the flowcharts of the Committ…
Source ↗Publisher website ·- Peer review 13. Peer review and confidentiality
Double-blind peer review; usually 2 expert referees. Model summary
Peer review is an integral part of scientific publishing that confirms the validity of the science reported. Peer reviewers are experts who volunteer their time to help improve the journal manuscripts they review. MRE Press follows COPE’s Ethical Guidelines for Peer Reviewers and employs ‘double-blind’ reviewing, in which the referees remain anonymous to the author(s) throughout and following the …
Source ↗Publisher website ·- Plagiarism 11. Plagiarism and other fraud
It is the responsibility of the authors to ensure that they pay particular attention to the originality of their work. Upon submission, all manuscripts are rigorously evaluated to identify any previously published material. MRE Press utilizes a combination of iThenticate, and searching on titles in PubMed and Google, to screen submitted manuscripts against published studies and other relevant sour…
Source ↗Publisher website ·- Trial registration / reporting guidelines
Clinical trials must be registered; TRN and registration date included in abstract. Model summary
Authors reporting the use of a new procedure or tool in a clinical setting, must give a clear justification in the manuscript for why the new procedure or tool was deemed more appropriate than usual clinical practice to meet the patient’s clinical need, and should obtain ethics approval and informed patient consent for participation in the study.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- MRE PRESS
- Country or region
- Singapore
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1980
- ISSN
- 0392-2936
- Electronic ISSN
- 2709-0086
- Latest issue on the website
- Volume 47, Issue 2 (April 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about European Journal of Gynaecological Oncology
What CAS zone is European Journal of Gynaecological Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, European Journal of Gynaecological Oncology is in Zone 4 of Medicine, and in Zone 4 of the minor category Obstetrics & Gynecology / Oncology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of European Journal of Gynaecological Oncology?
The latest impact factor listed by LetPub is 0.26; CiteScore 0.3, h-index 10.
How long does peer review take at European Journal of Gynaecological Oncology?
Authors report an average review time of about 2 months; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index European Journal of Gynaecological Oncology?
According to LetPub and DOAJ records, European Journal of Gynaecological Oncology is indexed in Scopus.
Is European Journal of Gynaecological Oncology open access, and what is the APC?
European Journal of Gynaecological Oncology is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .